Font Size: a A A

The Clinical Observation Of Chaiqinjieyu Decoction In The Treatment Of Non-alcoholic Fatty Liver With Liver Depression And Spleen Deficiency

Posted on:2020-10-24Degree:MasterType:Thesis
Country:ChinaCandidate:X N MaFull Text:PDF
GTID:2404330575490712Subject:Chinese medical science
Abstract/Summary:PDF Full Text Request
Objective:To observe the clinical effect of Chaiqinjieyu decoction on non-alcoh-olic fatty liver with liver depression and spleen deficiency,explore its mechanism,and evaluate its efficacy and safety.To provide new ideas and new methods for the treatment of non-alcoholic fatty liver with liver depression and spleen deficiency.Methods :Sixty patients were collected from the outpatient department and divided into two groups by random Numbers.The treatment group was treated with Chaiqinjieyu decoction,and the control group was treated with Sanqi Zhigan pill,both groups were treated for eight weeks.The changes of TCM symptoms,liver color doppler ultrasound,liver function and blood lipid before and after treatment in the two groups were recorded by the fixation staff.The collected data were sorted out and then statistical analysis was carried out with professional statistical software to explore the mechanism and make safety analysis.Meanwhile,patients were closely monitored for adverse reactions during medication.Results :1.After treatment,in the aspect of TCM syndrome integral,the treatment group total effective rate was 93.33 %,in the control group total effective rate was 80.00%,two group total effective rate is statistically significant difference(P < 0.05).2.After treatment,two groups of patients with blood lipid(TG,TC),liver function(ALT,AST,GGT)before treatment were improved,and the treatment group is better than that of control group,the difference statistically significant(P < 0.05);3.In colour to exceed the liver histological aspects,treatment group total effective rate was 93.33 %control group total effective rate was 63.33 %and the treatment group is better than that of control group,the difference is statistically significant(P < 0.05).Conclusion:1.Chaiqinjieyu decoction can effectively improve clinical syndrome type change in patients with NAFLD;2.Chaiqinjieyu decoction can effectively improve change in patients with NAFLD liver function,blood lipid levels,liver exceeds the pathological manifestations.
Keywords/Search Tags:Chaiqinjieyu decoction, Liver depression and spleen deficiency, Non-alcoholic fatty liver disease, Clinical observation
PDF Full Text Request
Related items
Clinical Observation Of Shugan Tiaozhi Decoction In The Treatment Of Non-Alcoholic Fatty Liver Disease Of Liver Depression And Spleen Deficiency
Sedum Tune Clinical Studies Of Nonalcoholic Fatty Liver Stagnation And Spleen Deficiency Syndrome Liver Recipe
Clinical Observation Of Granules Prescription Of Soothing Liver And Invigorating Spleen On Patients With Liver Qi Depression And Spleen Deficiency Syndrome Of Type 2 Diabetes Mellitus And Non-alcoholic Fatty Liver Disease
Clinical Observation On The Treatment Of Non Alcoholic Fatty Liver Disease Of Liver Depression And Spleen Deficiency Type With Chaihu Guizhi Ganjiang Decoction
The Clinical Observation Of Tiaozhihuoxuedecoction In The Treatment Of Non-alcoholic Fatty Liver Disease With Liver Depression And Spleen Deficiency Syndrome
Clinical Efficacy Of Jianpishu Shugan Qinghua Decoction On Non-alcoholic Fatty Liver Disease With Stagnation Of Liver Qi And Spleen Deficiency
Clinical Study On The Treatment Of Non Alcoholic Fatty Liver Disease Of Stagnation Of Liver-Qi With Deficiency Of The Spleen Complicated With Damp-Heat Syndrome With Qinganjiangzhi Decoction
Clinical Observation On The Treatment Of Liver Depression And Spleen Deficiency Type CHB Combined With NAFLD With Xiaoyao Powder And Buzhong Yiqi Decoction
Clinical Observation Of Jiawei Lancao Decoction In Treating Type 2 Pre-diabetes With Nonalcoholic Fatty Liver(Hepatic Depression And Spleen Deficiency Syndrome)
10 Clinical Observation On Xiaoyao Jianpi Decoction In The Treatment Of Liver Depression And Spleen Deficiency Syndrome In Non-alcoholic Fatty Liver Diseas